Table 1:

Gender and Cancer Type of Survey Participants

Category	Subcategory	Number of Studies Included N (%)	Number of Cancer Patients Included N (%)	Gender, N (%)*	Cancer Types Surveyed N (%)**,***
Total		25 (100)	6,878 (100)	M: 2,676 (42.3) F: 3,651 (57.7)	Br: 1,140 (24.1), HN: 333 (7.1), L: 74 (1.6), GI: 378 (8.0), Gy: 335 (7.1), GU: 218 (4.6), He: 1447 (30.6) O: 798 (16.9)
Income Class
	Low Income Countries	5 (20.0)	757 (11.0)	M: 281 (37.1) F: 476 (62.9)	Br: 191 (44.7), HN: 22 (5.2), GI: 31 (7.3), Gy: 53 (12.4), GU: 9 (2.1), He: 64 (15.0), O: 57 (13.3)
	Lower-Middle Income Countries	20 (80.0)	6,121 (89.0)	M: 2395 (43) F: 3,175 (57)	Br: 949 (22.1), HN: 311 (7.2), L: 74 (1.7), GI: 347 (8.1), Gy: 282 (6.6), GU: 209 (4.9), He: 1383 (32.2), O: 741 (17.2)
World Region
	Sub-Saharan Africa	11 (44.0)	2,091 (30.4)	M: 803 (38) F: 1287 (62)	Br: 545 (30.9), HN 137 (7.8), L: 4 (0.2), GI: 67 (3.8), Gy: 214 (12.2), GU: 64 (3.6), He: 452 (25.7), O: 278 (15.8)
	Middle East and North Africa	3 (12.0)	587 (8.5)	M: 149 (25) F: 438 (75)	Br: 236 (40.2), HN: 53 (9.0), L: 20 (3.4), GI: 62 (10.6), Gy: 25 (4.3), He: 184 (31.3), O: 7 (1.2)
	South Asia	8 (32.0)	3,511 (51.0)	M: 1,423 (48.1) F: 1,538 (51.9)	Br: 284 (16.8), HN: 143 (8.5), L: 50 (3.0), GI: 75 (4.4), Gy: 96 (5.7), GU: 14 (0.8), He: 662 (39.3), O: 362 (21.5)
	Latin America and Caribbean	1 (4.0)	100 (1.5)	M: 63 (63.0) F: 37 (37.0)	He: 77 (77.0), O: 23 (23.0)
	East Asia and Pacific	2 (8.0)	589 (8.6)	M: 238 (40.4) F: 351 (59.6)	Br: 75 (12.7), GI: 174 (29.5), GU: 140 (23.8), He: 72 (12.2), O: 128 (21.7)

^*Denominator for gender analysis is sum of male (n) + female (n) from studies that provided gender information

^**Denominator for cancer type analysis is sum of all cancer types (n) from studies that provided cancer type information

^***Br = Breast, HN = Head & Neck, L = Lung and Respiratory, GI = Gastrointestinal and Abdominal, Gy = Gynecological, He = Hematological, O: Others